Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

main

Biosimilars Webinar Series

Guide to Biosimilars Litigation and Regulation in the U.S. Webinar Series

Biosimilars Webinar Series

Contacts

Yoko J. Bian, Ph.D.

Naomi Birbach

Elaine Herrmann Blais

James Breen

Linnea P. Cipriano

Natasha E. Daughtrey

Biosimilars Webinar Series

So You Want To Make A Biosimilar: Top Considerations Before BLA Submission

Patent Dance Disclosures and Beyond: Recent Biosimilars Litigation at the District Court

Biosimilars Patent Challenges at the PTAB

An Overview of the Biosimilars Market in China

The Inflation Reduction Act & Medicare Pricing for Drugs and Biologics

Clinical Trials, Marketing and Labeling: Strategies for Proving and Defending Induced Infringement of Biosimilars

Contacts

Yoko J. Bian, Ph.D.

Naomi Birbach

Elaine Herrmann Blais

James Breen

Linnea P. Cipriano

Natasha E. Daughtrey